Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma

Christian Winther Eskelund; Alexandra Albertsson-Lindblad; Arne Kolstad; Anna Laurell; Riikka Räty; Lone Bredo Pedersen; Christian Hartmann Geisler; Mats Jerkeman; Kirsten Gronbaek

doi:10.3324/haematol.2018.194399

Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma

Christian Winther Eskelund, Alexandra Albertsson-Lindblad, Arne Kolstad, Anna Laurell, Riikka Räty, Lone Bredo Pedersen, Christian Hartmann Geisler, Mats Jerkeman, Kirsten Gronbaek

Research output: Contribution to journal › Letter › Scientific

Original language	English
Journal	Haematologica
Volume	103
Issue number	11
Pages (from-to)	E541-E543
Number of pages	3
ISSN	0390-6078
DOIs	https://doi.org/10.3324/haematol.2018.194399
Publication status	Published - 31 Oct 2018
MoE publication type	B1 Journal article

Fields of Science

HIGH-DOSE CYTARABINE
PROGNOSTIC VALUE
OPEN-LABEL
YOUNGER
TRIALS
KI-67
3122 Cancers

Access to Document

10.3324/haematol.2018.194399

haematol.2018.194399.fullAccepted author manuscript, 1.08 MB
e541.fullFinal published version, 562 KB

Cite this

@article{fe832dd83eba4011966df7d8cbb8cc0d,

title = "Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma",

keywords = "HIGH-DOSE CYTARABINE, PROGNOSTIC VALUE, OPEN-LABEL, YOUNGER, TRIALS, KI-67, 3122 Cancers",

author = "Eskelund, {Christian Winther} and Alexandra Albertsson-Lindblad and Arne Kolstad and Anna Laurell and Riikka R{\"a}ty and Pedersen, {Lone Bredo} and Geisler, {Christian Hartmann} and Mats Jerkeman and Kirsten Gronbaek",

year = "2018",

month = oct,

day = "31",

doi = "10.3324/haematol.2018.194399",

language = "English",

volume = "103",

pages = "E541--E543",

journal = "Haematologica",

issn = "0390-6078",

publisher = "FERRATA STORTI FOUNDATION",

number = "11",

}

TY - JOUR

T1 - Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma

AU - Eskelund, Christian Winther

AU - Albertsson-Lindblad, Alexandra

AU - Kolstad, Arne

AU - Laurell, Anna

AU - Räty, Riikka

AU - Pedersen, Lone Bredo

AU - Geisler, Christian Hartmann

AU - Jerkeman, Mats

AU - Gronbaek, Kirsten

PY - 2018/10/31

Y1 - 2018/10/31

KW - HIGH-DOSE CYTARABINE

KW - PROGNOSTIC VALUE

KW - OPEN-LABEL

KW - YOUNGER

KW - TRIALS

KW - KI-67

KW - 3122 Cancers

U2 - 10.3324/haematol.2018.194399

DO - 10.3324/haematol.2018.194399

M3 - Letter

SN - 0390-6078

VL - 103

SP - E541-E543

JO - Haematologica

JF - Haematologica

IS - 11

ER -